GENPREX
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
GENPREX
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.genprex.com
Total Employee:
1+
Status:
Active
Contact:
(512)537-7997
Total Funding:
71.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
OncoImmune
OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Inception Fund
Inception Fund investment in Venture Round - Genprex
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-21 | Genprex Appoints Shannon Inman as Vice President of Global Clinical Operations |
Official Site Inspections
http://www.genprex.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.92 K
- Host name: 104.21.48.189
- IP address: 104.21.48.189
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Genprex"
Genprex - Crunchbase Company Profile & Funding
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s …See details»
Company Profile - Genprex
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. (877) 774-GNPX (4679) 3300 Bee Cave …See details»
About Us - Genprex
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Our …See details»
Genprex Inc. (NASDAQ: GNPX) - IBN (InvestorBrandNetwork)
Investment Considerations Genprex Inc. (GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes. The …See details»
Genprex Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Genprex is a gene therapy company developing treatments for cancer and diabetes. Its cancer therapies are based upon a technology platform, including its lead drug …See details»
Genprex - VentureRadar
Genprex is a privately held, clinical-stage biopharmaceutical company focusing on developing breakthrough immunogene therapies with their lead product Oncoprex. Oncoprex is currently …See details»
Genprex, Inc. (LON: 0A8I) Company Profile & Overview - Stock …
Jan 10, 2025 Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to …See details»
Genprex 2025 Company Profile: Stock Performance
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for …See details»
Genprex, Inc. Company Overview, Contact Details & Competitors
May 7, 2018 Genprex, Inc. hires Jose A. Moreno Toscano as non-executive Chairman of the Board. AUSTIN, Texas, May 13, 2024 /PRNewswire/ - Genprex, Inc. ("Genprex" or the …See details»
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene …
Sep 23, 2024 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer …See details»
Investors - Genprex
Mar 17, 2019 Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. (877) 774-GNPX (4679) 3300 Bee …See details»
Genprex Inc | NASDAQ: GNPX | Gene Therapy Cancer
Sep 23, 2024 [email protected]. Interview conducted by: Lynn Fosse, Senior Editor. CEOCFO Magazine. Published – September 23, 2024. CEOCFO: Mr. Confer, Genprex is …See details»
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene
Sep 23, 2024 Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In …See details»
Genprex Provides Update on Diabetes Gene Therapy Program
Feb 18, 2025 About Genprex, Inc. Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.See details»
Company Management – Genprex
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. (877) 774-GNPX (4679) 3300 Bee Cave …See details»
Genprex Collaborators Selected to Present Positive Preclinical Data …
Mar 25, 2025 Novel Gene Therapy Program is Addressing Type 1 and Type 2 Diabetes. AUSTIN, Texas — (March 25, 2025) — Genprex, Inc. (“Genprex” or the “Company”) …See details»
Genprex Collaborators to Present Positive Preclinical Data on the …
6 days ago Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer …See details»
Genprex Inc. (GNPX) reports earnings - Quartz
1 day ago Genprex Inc. (GNPX-7.82%) has submitted its 10-K filing for the fiscal year ended December 31, 2024. Suggested Reading The 10 most dishonest states in America — …See details»
Genprex, Inc. SEC 10-K Report — TradingView News
1 day ago Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has released its 2024 10-K report. …See details»
Genprex Announces Plans to Launch Separate Company to Focus …
Sep 4, 2024 Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are …See details»